The kinetics of refolding of Escherichia coli dihydrofolate reductase (EC 1.5.1.3) have been examined upon dilution of unfolded enzyme in 4.5 M urea to 1.29 M urea in 0.02 M phosphate buffer (pH 7.2) at 100C. Changes in the intrinsic protein fluorescence on refolding are characterized by four phases. Based on changes in the amplitudes of these phases, as a consequence of quenching of the intrinsic fluorescence by ligands, it is possible to determine the step at which a ligand binds during the refolding process. The results show that either NADP or NADPH binds to the last species formed in a sequence involving three intermediates between the unfolded and native states. Dihydrofolate, on the other hand, binds during the formation of the second observed intermediate. When refolding is performed in the presence of methotrexate, an analogue of dihydrofolate, and NADPH, NADPH binds, as determined from changes in NADPH fluorescence, to the third observed intermediate rather than the last (fourth) species formed. Measurements of the recovery of enzymatic activity during refolding suggest that dihydrofolate also induces NADPH binding prior to the final observed folding phase. These results define more closely the formation of structural domains during the folding of dihydrofolate reductase.
Dihydrofolate reductase (DHF reductase; EC 1.5.1.3) has been the subject of intense study with respect to its threedimensional structure (1-3), its kinetic mechanism (4-7), and its folding properties (8) (9) (10) (11) (12) . As pointed out by Touchette et al. (8) , the Escherichia coli enzyme is a particularly good model for folding studies and Matthews and coworkers have characterized the wild-type enzyme as well as a number of site-directed mutants using urea as the denaturant (9) (10) (11) (12) . In addition to the wealth of available information about the E. coli enzyme, another distinction of this small (Mr = 17,680) globular protein is that it requires two ligands for enzymatic activity. The purpose of the present report shows that the binding sites for DHF and NADP(H) form sequentially and that the formation of these binding sites is associated with fluorescence changes observed during the folding process.
MATERIALS AND METHODS Materials. Urea solutions used in refolding experiments were made from 10 M stock solutions, prepared by dissolving fresh ultrapure urea (Schwarz/Mann) in 0.02 M potassium phosphate buffer/0.1 mM disodium ethylenediaminetetraacetate (Na2EDTA)/l mM dithioerythritol, pH 7.2, at 100C. This solution was filtered through a 0.2-gm Millipore filter and its concentration was determined with an Abbe refractometer (Bausch and Lomb). Urea solutions were stored at -20'C until used. Reduced nicotinamide adenine dinucleotide phosphate (NADPH), nicotinamide adenine dinucleotide phosphate (NADP), and methotrexate were obtained from Sigma. DHF was prepared from folic acid (13) and stored at -70'C in 5 mM HCI containing 50 mM 2-mercaptoethanol. All other chemicals were reagent grade.
Protein Purification. DHF reductase was isolated from E. coli strain HB101 containing the plasmid pTY1, a derivative of pBR322 containing a 2-kilobase insert coding for E. coli enzyme. Protein purification followed standard procedures (14, 15) . To rid enzyme preparations of residual folate left from the methotrexate affinity-chromatography step, the purified enzyme was brought to 90% saturation with solid ammonium sulfate; the precipitate was pelleted and redissolved in 50 mM potassium phosphate/2 mM dithioerythritol/2 mM Na2EDTA/3 M guanidine hydrochloride, pH 7.0, at 40C and then dialyzed exhaustively against the same buffer. The enzyme was renatured by dialysis against the same buffer without guanidine hydrochloride. The enzyme was then centrifuged at 10,000 x g for 30 min to remove any denatured enzyme. The soluble, renatured enzyme was decanted, and protein concentration was determined by activesite titration with methotrexate (16) . These preparations were used within 10 days.
Folding Studies. The time course of fluorescence changes was measured using an Applied Photophysics (Surrey, U.K.) stopped-flow spectrophotometer in the fluorescence mode with a path length of either 0.2 or 1.0 cm. Results were similar for either. All experiments were performed in 0.02 M phosphate buffer at 100C, pH 7.2, containing 1 mM dithioerythritol and 0.1 mM EDTA. The drive syringes were of different volumes such that there was a 3.5-fold dilution of the urea solution containing the enzyme, the smaller syringe containing the enzyme and urea and the larger syringe containing buffer or buffer plus ligand(s). Experiments in which different ligands were compared were performed on the same day using exactly the same conditions of photomultiplier voltage and light intensity, but results from experiments performed on different days were quite reproducible. The initial concentration of urea was 4.5 M and that of the enzyme was 0.51 mg/ml. After mixing, the urea concentration was 1.29 M and the enzyme concentration was 0.15 mg/ml (8.5 1LM). For measurements using the intrinsic fluorescence of the protein, the excitation wavelength was 285 nm, slit widths were set to 2 mm, and fluorescence was observed using a 305-nm cutoff filter. In the case of NADPH a 305-nm cutoff filter in conjunction with a UG1 band pass filter was used. Fluorescence data were usually collected using the dual time base mode of the instrument with 500 points being collected over the first few seconds and another 500 points collected over the next 250 sec. When changes in fluorescence of NADPH were measured, the excitation wavelength was 340 nm using the 1-cm cell and 385-nm cutoff filter. When activity measurements were made, the 1-cm absorbance cell was used at a wavelength of 340 nm. (8), fluorescence changes on refolding DHF reductase from high to low urea concentrations first show an increase and then a decrease in fluorescence. As indicated above, the data are best fit with a sum of four exponentials representing at least four phases in refolding. Such data in the absence or presence of DHF or NADP are shown in Fig. 1 . The initial concentration of urea, 4.5 M, is reasonably far above the midpoint of the urea inactivation curve (-3.5 M under these conditions) and the final concentration (1.29 M) is well below that midpoint. Essentially similar data were obtained when the initial urea concentration was 6 M and the final concentration was 1.71 M (data not shown). Experiments that measure the total change in fluorescence as a function of urea concentration indicate that the changes observed in the kinetic measurements are approximately the same as expected for the total change for unfolded to folded forms of the enzyme under these conditions. The same observation was made by Touchette et al. (8) using absorbance changes. The rate constants and corresponding amplitudes for the enzyme in the absence of ligand are shown in the first line of Table 1 .
It has been previously observed that when ligands such as NADP or DHF are added to native enzyme, there is a decrease in the fluorescence (4). This decrease is over and above that observed on refolding and occurs in at least two phases, a rapid phase (over in <5 msec) as a consequence of binding and then a second slower change reflecting a conformational change (19 (19) . It should be noted that Table 1 shows that the rate constants for the . Using the mechanism of Scheme I, the changes in amplitudes observed upon addition of NADP or NADPH to the refolding enzyme show that these ligands bind to only the final species, designated N. DHF, on the other hand, binds early in the refolding process, presumably during the conversion of the I1 species to the I2 since the amplitude represented by IH -*12 is increased when DHF is added at the start of refolding. Table 1 shows, in fact, that the amplitudes of the remaining two phases are also increased. As indicated earlier, this is probably a consequence of slow conformational changes induced by DHF binding.
Scheme I can, therefore, be expanded to include the binding steps as shown in Scheme II. shows substrate disappearance in 1.29 M urea. Curve B is the activity recovery on dilution from 4.5 M to 1.29 M urea. Superimposed on the experimental data for curve A is the computer-simulated curve for a kinetic mechanism describing the progress curves for the enzyme. Using the same kinetic parameters found for curve A but starting with the unfolded enzyme and the rate constants for folding given in line 1 of Table 1 and assuming that activity is recovered with the final phase of folding gives curve C, which does not describe the real data (curve B). The simulated curve fitting the real data for activity recovery during refolding (superimposed on curve B) assumes that NADPH binds to an earlier intermediate as described in the text. Other experimental conditions are described in the legend to Fig. 1 
